These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20955413)

  • 41. Nanofluidic Allele-Specific Digital PCR Method for Quantifying IDH1 and IDH2 Mutation Burden in Acute Myeloid Leukemia.
    Wiseman DH; Somervaille TCP
    Methods Mol Biol; 2017; 1633():235-255. PubMed ID: 28735491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation of Isocitrate Dehydrogenase 1 and 2 Mutations in Acute Leukemia Patients in Saudi Arabia.
    Alkhatabi H; Bin Saddeq HA; Alyamani L; Shinawi T; Yasin EB; Alserihi R; Felimban R; Tayeb HH; Mimani R; Alalla Z; Abu-Elmagd M; Abuzenadah A
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing.
    Felsberg J; Wolter M; Seul H; Friedensdorf B; Göppert M; Sabel MC; Reifenberger G
    Acta Neuropathol; 2010 Apr; 119(4):501-7. PubMed ID: 20131059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.
    Thol F; Weissinger EM; Krauter J; Wagner K; Damm F; Wichmann M; Göhring G; Schumann C; Bug G; Ottmann O; Hofmann WK; Schlegelberger B; Ganser A; Heuser M
    Haematologica; 2010 Oct; 95(10):1668-74. PubMed ID: 20494930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Research Advances of IDH2 Gene Mutation in Acute Myeloid Leukemia].
    Zhao YX; Shen XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):632-6. PubMed ID: 27151043
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IDH2 mutations in patients with acute myeloid leukemia: missense p.R140 mutations are linked to disease status.
    Jeziskova I; Razga F; Bajerova M; Racil Z; Mayer J; Dvorakova D
    Leuk Lymphoma; 2010 Dec; 51(12):2285-7. PubMed ID: 20929327
    [No Abstract]   [Full Text] [Related]  

  • 47. IDH mutations in glioma and acute myeloid leukemia.
    Dang L; Jin S; Su SM
    Trends Mol Med; 2010 Sep; 16(9):387-97. PubMed ID: 20692206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Minimal Residual Disease assessment of IDH1/2 mutations in Acute Myeloid Leukemia by LNA-RQ-PCR.
    Abdelhamid E; Besbes S; Renneville A; Nibourel O; Helevaut N; Preudhomme C; Soua Z
    Tunis Med; 2016 Mar; 94(3):190-7. PubMed ID: 27575502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of high-frequency and novel DNMT3A mutations in acute myeloid leukemia by high-resolution melting curve analysis.
    Singh RR; Bains A; Patel KP; Rahimi H; Barkoh BA; Paladugu A; Bisrat T; Ravandi-Kashani F; Cortes JE; Kantarjian HM; Medeiros LJ; Luthra R
    J Mol Diagn; 2012 Jul; 14(4):336-45. PubMed ID: 22642896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of IDH1 mutations identified with PCR-RFLP assay in acute myeloid leukemia patients.
    Elsayed GM; Nassar HR; Zaher A; Elnoshokaty EH; Moneer MM
    J Egypt Natl Canc Inst; 2014 Mar; 26(1):43-9. PubMed ID: 24565682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum 2-hydroxyglutarate production in IDH1- and IDH2-mutated de novo acute myeloid leukemia: a study by the Acute Leukemia French Association group.
    Janin M; Mylonas E; Saada V; Micol JB; Renneville A; Quivoron C; Koscielny S; Scourzic L; Forget S; Pautas C; Caillot D; Preudhomme C; Dombret H; Berthon C; Barouki R; Rabier D; Auger N; Griscelli F; Chachaty E; Leclercq E; Courtier MH; Bennaceur-Griscelli A; Solary E; Bernard OA; Penard-Lacronique V; Ottolenghi C; de Botton S
    J Clin Oncol; 2014 Feb; 32(4):297-305. PubMed ID: 24344214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Isocitrate dehydrogenase gene mutations in acute myeloid leukemia].
    Zhou XJ; Zhang SJ; Qiao C; Shen YF; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):902-6. PubMed ID: 21867611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of mutations in the isocitrate dehydrogenase genes in therapy-related and secondary acute myeloid leukaemia identifies a patient with clonal evolution to IDH2 R172K homozygosity due to uniparental disomy.
    Pichler MM; Bodner C; Fischer C; Deutsch AJ; Hiden K; Beham-Schmid C; Linkesch W; Guelly C; Sill H; Wölfler A
    Br J Haematol; 2011 Mar; 152(5):669-72. PubMed ID: 21250968
    [No Abstract]   [Full Text] [Related]  

  • 54. Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia.
    Kövy P; Őrfi Z; Bors A; Kozma A; Gopcsa L; Dolgos J; Lovas N; Harasztdombi J; Lakatos V; Király Á; Mikala G; Vályi-Nagy I; Reményi P; Andrikovics H
    PLoS One; 2021; 16(6):e0253386. PubMed ID: 34153064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IDH1 and IDH2 mutations in therapy-related myelodysplastic syndrome and acute myeloid leukemia are associated with a normal karyotype and with der(1;7)(q10;p10).
    Westman MK; Pedersen-Bjergaard J; Andersen MT; Andersen MK
    Leukemia; 2013 Apr; 27(4):957-9. PubMed ID: 23192014
    [No Abstract]   [Full Text] [Related]  

  • 56.
    Pasca S; Jurj A; Tomuleasa C; Zdrenghea M
    Medicina (Kaunas); 2020 Nov; 56(12):. PubMed ID: 33255417
    [No Abstract]   [Full Text] [Related]  

  • 57. Differential prognostic impact of IDH1 and IDH2 mutations in chronic myelomonocytic leukemia.
    Walsh C; Hunter A; Lasho T; Finke C; Ketterling R; Komrokji R; Tefferi A; Mangaonkar A; Howard M; Gangat N; Al-Kali A; Ali NA; Padron E; Patnaik MM
    Leukemia; 2022 Jun; 36(6):1693-1696. PubMed ID: 35351982
    [No Abstract]   [Full Text] [Related]  

  • 58. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations.
    Gross S; Cairns RA; Minden MD; Driggers EM; Bittinger MA; Jang HG; Sasaki M; Jin S; Schenkein DP; Su SM; Dang L; Fantin VR; Mak TW
    J Exp Med; 2010 Feb; 207(2):339-44. PubMed ID: 20142433
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Srinivasan A; Zhou Y; Scordino T; Prabhu S; Wierenga A; Simon G; Wierenga KJ; Thompson J; Shah R; Sinha AA
    Pediatr Hematol Oncol; 2020 Aug; 37(5):431-437. PubMed ID: 32166993
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased levels of 2-hydroxyglutarate in AML patients with IDH1-R132H and IDH2-R140Q mutations.
    Sellner L; Capper D; Meyer J; Langhans CD; Hartog CM; Pfeifer H; Serve H; Ho AD; Okun JG; Krämer A; Von Deimling A
    Eur J Haematol; 2010 Nov; 85(5):457-9. PubMed ID: 20659156
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.